ATE113468T1 - Verfahren zur trennung von teilchen nach grösse. - Google Patents

Verfahren zur trennung von teilchen nach grösse.

Info

Publication number
ATE113468T1
ATE113468T1 AT88906769T AT88906769T ATE113468T1 AT E113468 T1 ATE113468 T1 AT E113468T1 AT 88906769 T AT88906769 T AT 88906769T AT 88906769 T AT88906769 T AT 88906769T AT E113468 T1 ATE113468 T1 AT E113468T1
Authority
AT
Austria
Prior art keywords
particles
size
separation
tangential flow
liposomes
Prior art date
Application number
AT88906769T
Other languages
English (en)
Inventor
Robert P Lenk
Anthony G Durning
Robert J Klimchak
Joel Portnoff
Michelle L Tomsho
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26761847&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE113468(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of ATE113468T1 publication Critical patent/ATE113468T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03B—APPARATUS OR ARRANGEMENTS FOR TAKING PHOTOGRAPHS OR FOR PROJECTING OR VIEWING THEM; APPARATUS OR ARRANGEMENTS EMPLOYING ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ACCESSORIES THEREFOR
    • G03B2227/00—Photographic printing apparatus
    • G03B2227/32—Projection printing apparatus, e.g. enlarging apparatus, copying camera
    • G03B2227/325—Microcapsule copiers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Devices And Processes Conducted In The Presence Of Fluids And Solid Particles (AREA)
AT88906769T 1987-07-29 1988-07-28 Verfahren zur trennung von teilchen nach grösse. ATE113468T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7930987A 1987-07-29 1987-07-29
US16458088A 1988-03-07 1988-03-07

Publications (1)

Publication Number Publication Date
ATE113468T1 true ATE113468T1 (de) 1994-11-15

Family

ID=26761847

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88906769T ATE113468T1 (de) 1987-07-29 1988-07-28 Verfahren zur trennung von teilchen nach grösse.

Country Status (5)

Country Link
EP (1) EP0394265B1 (de)
JP (1) JP2877160B2 (de)
AT (1) ATE113468T1 (de)
DE (1) DE3852037T2 (de)
WO (1) WO1989000846A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049392A (en) * 1989-01-18 1991-09-17 The Liposome Company, Inc. Osmotically dependent vesicles
US5958449A (en) * 1992-12-02 1999-09-28 Nexstar Pharmaceuticals, Inc. Antibiotic formulation and use for bacterial infections
WO1994012155A1 (en) * 1992-12-02 1994-06-09 Vestar, Inc. Antibiotic formulation and process
US5759571A (en) * 1993-05-11 1998-06-02 Nexstar Pharmaceuticals, Inc. Antibiotic formulation and use for drug resistant infections
DE69426884T2 (de) 1993-07-08 2001-06-21 The Liposome Co.,Inc. Verfahren zum kontrollieren der liposomengrösse
IL115849A0 (en) * 1994-11-03 1996-01-31 Merz & Co Gmbh & Co Tangential filtration preparation of liposomal drugs and liposome product thereof
ES2343767T3 (es) 1997-09-18 2010-08-09 Pacira Pharmaceuticals, Inc. Composiciones anestesicas liposomicas de liberacion sostenida.
JP4575592B2 (ja) * 1997-11-14 2010-11-04 パシラ ファーマシューティカルズ インコーポレーテッド 多小胞リポソームの製造
US6165997A (en) * 1997-11-20 2000-12-26 Statens Serum Institut Phospholipids having antimicrobial activity with or without the presence of antimicrobials
FR2788780B1 (fr) * 1999-01-27 2001-03-30 Ap Cells Inc Procede de preparation de vesicules membranaires
AU2003262048A1 (en) * 2002-09-11 2004-04-30 Tanabe Seiyaku Co., Ltd. Process for the production of microspheres and unit therefor
EP1874443A4 (de) * 2005-04-29 2009-09-16 Univ Rochester Ultradünne poröse nanoskalige membranen, herstellungsverfahren dafür und verwendungen davon
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
EP2309991B1 (de) 2008-06-16 2019-03-06 Pfizer Inc Therapeutische polymernanopartikel mit vincaalkaloiden sowie verfahren zu ihrer herstellung und verwendung
EA020954B1 (ru) 2008-06-16 2015-03-31 Бинд Терапьютикс, Инк. Загруженные лекарственным средством полимерные наночастицы, фармацевтическая композиция и способ лечения рака
WO2010005726A2 (en) 2008-06-16 2010-01-14 Bind Biosciences Inc. Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
EP2379064B1 (de) 2008-12-15 2020-02-26 Pfizer Inc. Lange zirkulierende nanoteilchen zur verzögerten freisetzung von therapeutischen mitteln
GB0917003D0 (en) * 2009-09-28 2009-11-11 Novartis Vaccines Inst For Global Health Srl Purification of bacterial vesicles
TR201906255T4 (tr) 2009-12-11 2019-05-21 Pfizer Terapötik partiküllerin liyofilize edilmesine yönelik stabil formülasyonlar.
ES2780156T3 (es) 2009-12-15 2020-08-24 Pfizer Composiciones terapéuticas de nanopartículas poliméricas con alta temperatura de transición vítrea o copolímeros de alto peso molecular
EP2402075A1 (de) 2010-06-28 2012-01-04 Bühler AG Verfahren und Vorrichtung zur Herstellung von Vesikeln
PL2892524T3 (pl) 2012-09-04 2021-10-25 Eleison Pharmaceuticals, Llc Zapobieganie nawrotom płucnym przy użyciu cisplatyny w kompleksie z lipidami
EP2895156B1 (de) 2012-09-17 2019-05-08 Pfizer Inc. Verfahren zur herstellung therapeutischer nanopartikel
ES2834927T3 (es) 2014-03-14 2021-06-21 Pfizer Nanopartículas terapéuticas que comprenden un agente terapéutico y procedimientos de fabricación y uso de las mismas
SMT202000516T1 (it) 2014-05-15 2020-11-10 Insmed Inc Metodi per trattamento di infezioni micobatteriche polmonati non tubercolari
CA2953265C (en) * 2014-07-02 2023-09-26 Shire Human Genetic Therapies, Inc. Encapsulation of messenger rna
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
WO2019213398A1 (en) 2018-05-02 2019-11-07 Insmed Incorporated Methods for the manufacture of liposomal drug formulations
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
GB2627096A (en) 2021-10-14 2024-08-14 Pacira Pharmaceuticals Inc Bupivacaine multivesicular liposome formulations and uses thereof
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251468B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12246092B1 (en) 2024-05-20 2025-03-11 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0032578B1 (de) * 1980-01-16 1984-07-25 Hans Georg Prof. Dr. Weder Verfahren und Dialysiereinrichtung zur Herstellung von Bilayer-Vesikeln und Verwendung der Bilayer-Vesikel
US4420398A (en) * 1981-08-13 1983-12-13 American National Red Cross Filteration method for cell produced antiviral substances
US4888115A (en) * 1983-12-29 1989-12-19 Cuno, Incorporated Cross-flow filtration
DE3432718C1 (de) * 1984-09-06 1986-05-22 Biotest Pharma GmbH, 6000 Frankfurt Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen
FR2576805B1 (fr) * 1985-02-01 1989-08-25 Lyonnaise Eaux Appareil de filtration tangentielle
GB2176715A (en) * 1985-06-27 1987-01-07 Apv Int Ltd Beer filtration
IL79985A0 (en) * 1985-09-13 1986-12-31 Ausimont Spa Purification of oils containing solid matter in suspension

Also Published As

Publication number Publication date
WO1989000846A1 (en) 1989-02-09
JPH02504362A (ja) 1990-12-13
EP0394265A1 (de) 1990-10-31
EP0394265A4 (en) 1991-07-31
DE3852037D1 (de) 1994-12-08
JP2877160B2 (ja) 1999-03-31
EP0394265B1 (de) 1994-11-02
DE3852037T2 (de) 1995-03-23

Similar Documents

Publication Publication Date Title
DE3852037D1 (de) Verfahren zur trennung von teilchen nach grösse.
DE69107855D1 (de) Verbessertes verfahren und vorrichtung zur tangentiellen filtrierung.
DE69132172D1 (de) Verfahren zur Abtrennung von Blutkomponenten aus Vollblut
DE69019690D1 (de) Verfahren zur Filtrierung und Reinigung von Wasser.
DE68911412D1 (de) Verfahren zur Gas-Flüssig-Trennung und Filtration.
ATE48086T1 (de) Verfahren und vorrichtung zur selektiven extrakorporalen abtrennung pathologischer und/oder toxischer blutbestandteile.
DE69112197D1 (de) Verfahren zur Regeneration poröser keramischer Filter.
ATE70366T1 (de) Magnetische teilchen zur verwendung in trennungen.
DE69106100D1 (de) Verfahren zur Trennung durch Adsorption und Adsorber.
DE3856587D1 (de) Vorrichtung und Verfahren zur Verminderung des Leukocytengehalts von Blutkomponenten
DE3884352D1 (de) Pervaporationsverfahren zur Trennung von Alkoholen von Äthern.
DE69128679D1 (de) Filter zur Filtration von Flüssigkeit
DE69020248D1 (de) Filtermaterial zum Abscheiden von Leukozyten und Verfahren zu seiner Herstellung.
DE69307962D1 (de) Verfahren zur Herstellung von Filterzigaretten
DE68914001D1 (de) Verfahren zur Herstellung von Elektretfiltern.
DE68918706D1 (de) Verfahren und vorrichtung zur trockenentfernung von verunreinigungen aus gasströmen.
DE69031481D1 (de) Verfahren zur Gewinnung von Ginkgoliden aus Ginkgoblättern und ihre Reinigung
AT383963B (de) Filter zur abtrennung von gasfoermigen oder fluessigen komponenten aus fluiden und verfahren zu dessen herstellung
AT377709B (de) Filterapparat zur abtrennung von feststoffen aus fluessigkeiten
AT368749B (de) Verfahren zur kontinuierlichen herstellung von stickoxyd (no) und vorrichtung zur durchfuehrung des verfahrens
DE59009375D1 (de) Verfahren zur Abtrennung von Riboflavin aus Fermentationssuspensionen.
DE69010083D1 (de) Kontinuierliches Verfahren zur Trennung von teils in wasserlöslichen Bestandteilen aus einem Schlamm.
DE59105092D1 (de) Verfahren zur extraktiven Trennung von L-Phosphinothricin und L-Glutaminsäure in wässriger Lösung.
DE69111637D1 (de) Verfahren zur Trennung und Konzentration von Phosphopeptiden.
SE8601048D0 (sv) Verfahren zur herstellung eines filtermittels aus nichtmetallischem fasermaterial

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time